When will Azacitidine Injection be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Azacitidine Injection changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Azacitidine Injection

Brand names: Azacitidine, Vidaza

Category: Oncology

Unavailable 3Limited 1Available 5

FDA status: Current · Last FDA update: Sep 29, 2026 · First posted: Dec 18, 2020 (in shortage 5 years 9 months) · 9 manufacturers, 9 listed presentations

As of Sep 29, 2026, the FDA lists Azacitidine Injection as currently in shortage. Of 9 manufacturer presentations, 3 Unavailable, 1 Limited, 5 Available.

Ask your pharmacist: which of the 9 manufacturers below can they order right now, and whether a different strength or form of Azacitidine Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Azacitidine, Injection, 100 mg (NDC 68001-313-56) NDC 68001-313-56	Teva Pharmaceuticals USA, Inc.	Unavailable	Estimated recovery: TBD
Azacitidine, Injection, 100 mg (NDC 72485-201-01) NDC 72485-201-01	Armas Pharmaceuticals Inc	Limited	Estimated recovery: TBD
Azacitidine, Injection, 100 mg (NDC 16729-306-10) NDC 16729-306-10	Accord Healthcare Inc.	Available	-
Vidaza, Injection, 100 mg (NDC 59572-102-01) NDC 59572-102-01	Bristol Myers Squibb Co.	Available	-
Azacitidine, Injection, 100 mg (NDC 43598-305-62) NDC 43598-305-62	Dr. Reddy's Laboratories, Inc.	Available	Available to existing customers
Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01) NDC 0143-9606-01	Hikma Pharmaceuticals USA, Inc.	Available	Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.
Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39) NDC 63323-771-39	Fresenius Kabi USA, LLC	Unavailable	Discontinuation of the manufacture of the drug
Azacitidine, Injection, 100 mg/30 mL (NDC 71288-115-30) NDC 71288-115-30	Meitheal Pharmaceuticals, Inc.	Available	-
Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01) NDC 55150-393-01	Eugia US LLC	Unavailable	On backorder. Recovery: TBD. Check wholesalers for inventory

Related medications in shortage

Other Oncology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Azacitidine Injection (FDA data as of Sep 29, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Azacitidine Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Azacitidine Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/azacitidine-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).